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Background: The clinical feasibility of using high-intensity focused ultrasound (HIFU) for ablation of solid tumors is
limited by the high acoustic pressures and long treatment times required. The presence of microbubbles during
sonication can increase the absorption of acoustic energy and accelerate heating. However, formation of
microbubbles within the tumor tissue remains a challenge. Phase-shift nanoemulsions (PSNE) have been developed
as a means for producing microbubbles within tumors. PSNE are emulsions of submicron-sized, lipid-coated, and
liquid perfluorocarbon droplets that can be vaporized into microbubbles using short (<1 ms), high-amplitude
(>5 MPa) acoustic pulses. In this study, the impact of vaporized phase-shift nanoemulsions on the time and
acoustic power required for HIFU-mediated thermal lesion formation was investigated in vitro.
Methods: PSNE containing dodecafluoropentane were produced with narrow size distributions and mean
diameters below 200 nm using a combination of sonication and extrusion. PSNE was dispersed in albumin-
containing polyacrylamide gel phantoms for experimental tests. Albumin denatures and becomes opaque at
temperatures above 58°C, enabling visual detection of lesions formed from denatured albumin. PSNE were
vaporized using a 30-cycle, 3.2-MHz, at an acoustic power of 6.4 W (free-field intensity of 4,586 W/cm2) pulse from a
single-element, focused high-power transducer. The vaporization pulse was immediately followed by a 15-s
continuous wave, 3.2-MHz signal to induce ultrasound-mediated heating. Control experiments were conducted
using an identical procedure without the vaporization pulse. Lesion formation was detected by acquiring video
frames during sonication and post-processing the images for analysis. Broadband emissions from inertial cavitation
(IC) were passively detected with a focused, 2-MHz transducer. Temperature measurements were acquired using a
needle thermocouple.
Results: Bubbles formed at the HIFU focus via PSNE vaporization enhanced HIFU-mediated heating. Broadband
emissions detected during HIFU exposure coincided in time with measured accelerated heating, which suggested
that IC played an important role in bubble-enhanced heating. In the presence of bubbles, the acoustic power
required for the formation of a 9-mm3 lesion was reduced by 72% and the exposure time required for the onset of
albumin denaturation was significantly reduced (by 4 s), provided that the PSNE volume fraction in the
polyacrylamide gel was at least 0.008%.
Conclusions: The time or acoustic power required for lesion formation in gel phantoms was dramatically reduced
by vaporizing PSNE into bubbles. These results suggest that PSNE may improve the efficiency of HIFU-mediated
thermal ablation of solid tumors; thus, further investigation is warranted to determine whether bubble-enhanced
HIFU may potentially become a viable option for cancer therapy.
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High-intensity focused ultrasound (HIFU) is a medical
procedure for the treatment of solid tumors [1-6]. In this
procedure, ultrasound is focused into diseased tissue, and
a fraction of the acoustic energy is converted into heat,
primarily due to viscous absorption. Thermal ablation is
possible by heating the tissue beyond the threshold
temperature for protein denaturation. Using a focused
transducer, the maximum point of heat deposition can be
localized with millimeter precision. Thus, HIFU can be
used to ablate solid tumors with minimal thermal damage
to the surrounding and intervening tissue.
The focused ultrasound beam is normally generated
with a single-element spherically focused transducer or
by a transducer array. Because ultrasound can propagate
through the tissue, the HIFU treatment does not require
the insertion of probes and thus is noninvasive. In the
past decade, HIFU has been used widely and has proven
clinically to be successful in the treatment of a variety of
cancers [7-9]. However, HIFU treatment of cancers that
grow in organs behind by the rib cage or the skull (i.e.,
liver and brain cancers) is difficult because high attenu-
ation of ultrasound in the bone increases the risk of
thermal damage to the bone and the adjacent tissue.
Additionally, acoustic intensity at the focus is reduced
significantly, increasing the insonation time required for
lesion formation. Therefore, a method that can reduce
the acoustic power required for ablation and can in-
crease the accuracy of the treatment while maintaining
the therapeutic benefit will improve the clinical utility of
HIFU for cancer therapy.
It has been well documented that the presence of
microbubbles during sonication can increase the absorption
of acoustic energy and can accelerate heating, which poten-
tially could be used for increasing the efficiency of HIFU
ablation [10-17]. While the results from documented stud-
ies are encouraging, microbubbles are not readily available
in the tissue and thus must be created or introduced. Fo-
cused ultrasound can nucleate microbubbles in the tissue;
however, it has been predicted that the applied rarefactional
pressure must exceed 10 MPa in the absence of a nuclei
[18,19]. At such a high pressure, shock waves can form in
the tissue, and the absorption of shock waves may heat the
tissue beyond the boiling point in milliseconds [20]. Be-
cause boiling bubbles can distort the lesion geometry sig-
nificantly, the avoidance of boiling tissue is preferred
during HIFU-mediated ablation [21,22]. The introduction
of exogenous agents can serve as the nuclei for cavitation
in vivo, thus reducing the pressure threshold. Studies have
demonstrated that systemically administered ultrasound
contrast agents (UCAs) can nucleate cavitation for bubble-
enhanced heating [14,23-25]. However, the short lifespan of
UCAs in circulation (<10 min) limits their use for bubble-
enhanced thermal ablation [26,27]. Furthermore, UCAslocated in the blood vessels along the acoustic propagation
path may attenuate HIFU significantly, resulting in un-
wanted heating and thermal damage in the healthy inter-
vening tissue. The feasibility of using laser-illuminated gold
nanoparticles has also been demonstrated for nucleating
cavitation [28]. However, this method was limited to super-
ficial cancers due to lack of penetration of the laser in the
tissue. Therefore, a reliable and consistent approach to nu-
cleation locally within tumors is needed in order to take ad-
vantage of bubble-enhanced tumor ablation clinically.
In a previous study, we investigated the potential of
using phase-shift nanoemulsions (PSNE) for nucleating
microbubbles and reducing the pressure threshold for in-
ertial cavitation (IC) [29]. PSNE consist of nanodroplets
composed of liquid perfluorocarbon, such as dodeca-
fluoropentane (DDFP), and coated with phospholipids or
albumin. The boiling point of DDFP in bulk is 29°C at
standard atmospheric pressure, which is lower than
physiological temperature (37°C). However, when liquefied
DDFP is dispensed in the form of a nanoemulsion, DDFP
is stable in the liquid phase at temperatures approaching
70°C. This is most likely due to the surface tension, which
creates a pressure difference across the droplet interface
that is inversely proportional to the droplet radius (i.e.,
Laplace pressure). It has been predicted that as the internal
pressure is increased, the boiling point is elevated [30,31].
In our previous study, we produced nanoemulsions with a
mean diameter of 260 nm. Using the surface tension
reported for naked perfluoropentane (PFP) droplets of
56 ± 1 mN/m [32], the Laplace pressure for our nano-
emulsions was approximately 860 kPa. Nanoemulsions
must be coated with surface-active molecules (i.e., sur-
factant) in order to inhibit fusion, and Rapoport et al.
estimated that the coating may drop the surface tension
for PFP to 30 mN/m [31]. Using the Antoine equation
log10 P = A − B/(T + C) [33] and the Antoine constants
A = 6.87362, B = 1,075.780, and C = 233.205 which were
previously reported for n-pentane [34], we calculated a
boiling point of 90.8°C for our nanoemulsions.
While stable at physiological temperature, the PSNE can
be vaporized with short (<1 ms), high-amplitude (>5 MPa)
acoustic pulses, a process known as acoustic droplet
vaporization (ADV) [35]. In a previous study, we used
HIFU to vaporize PSNE dispersed throughout a polyacryl-
amide gel in a localized manner. The PSNE were vapor-
ized only at the transducer focus when the rarefactional
pressure exceeded a well-defined threshold (approximately
5 MPa); thus, HIFU provided a means to vaporize PSNE
with exceptional spatial specificity and precision (i.e., on
the order of millimeters). The PSNE reduced the pressure
required for bubble formation in the gel phantoms and re-
duced the pressure for the onset of IC. Unlike UCA, scat-
ter and attenuation from PSNE in liquid form are
negligible; thus, unvaporized PSNE along the propagation
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pulses. In addition, PSNE have no known toxicity, and
DDFP has previously been tested clinically [36]. Thus,
PSNE is a good candidate for localized bubble nucleation
in the tissue.
The main purpose of this study was to examine the
feasibility of using vaporized PSNE to accelerate HIFU
thermal lesion formation. The study was performed
using PSNE dispersed throughout optically transparent
albumin-containing gel phantoms, where lesion forma-
tion could be visualized and analyzed with video tech-
niques. Furthermore, an ultrasound protocol was designed
specifically for vaporizing the PSNE and driving bubble-
enhanced heating in a localized manner. For the ultra-
sound exposure, a short (<1 ms), high-amplitude acoustic
pulse was transmitted first to trigger acoustic droplet
vaporization followed by continuous wave (CW) sonic-
ation. The acoustic intensity of the continuous wave ex-
posure was below the ADV threshold; thus, we anticipate
that the vaporization of additional PSNE will be avoided,
limiting the impact of bubbles on HIFU ablation to the
focal volume. In addition, in this study, DDFP droplets
were coated with a phospholipid shell instead of albumin,
in order to achieve narrower size distributions through ex-
trusion. A narrower size distribution enables more reliable
control over PSNE vaporization, and the reduced size
would potentially increase the amount of PSNE accumula-
tion in tumors in vivo through enhanced permeability and
retention effect [37]. We hypothesized that vaporized
PSNE would significantly reduce the exposure time or
acoustic power needed for lesion formation. Additionally,
we explored the effect of inertial cavitation activity from
vaporized PSNE on HIFU-mediated heating. Finally, the
effect of PSNE concentration and acoustic intensity on
final lesion shape and location was investigated.
Methods
Preparation of lipid-based phase-shift nanoemulsion
The phase-shift nanoemulsions consisted of DDFP (C5F12,
CAS 678-26-2, Synquestlabs, Alachua, FL, USA) droplets,
which were dispersed in saline and stabilized with a
phospholipid monolayer shell. The shell components in-
cluded 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC,
Avanti Polar Lipids, Alabaster, AL, USA) and the lipopolymer
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000,
Avanti Polar Lipid) in the molar ratio of 25:1. DPPC
worked as an emulsifier to stabilize the emulsion from co-
alescence, and DSPE-PEG2000 served as a polymer brush,
limiting the interaction between droplets that could lead
to fusion [38].
The nanoemulsions were prepared by combining ultra-
sound emulsification and pressure extrusion methods
in order to get the desired mean diameter and sizedistribution. In the first step, 5.0 mg DPPC and 0.8 mg
DSPE-PEG2000 were mixed with chloroform in a round-
bottom flask. After mixing, the chloroform was removed
by evaporation under vacuum, leaving a dry thin lipid film.
The film was re-hydrated with 9.95 ml of saline to form a
lipid solution. In the second step, 0.05 ml DDFP was
added to the 9.95 ml of phospholipid saline solution and
then emulsified with an ultrasonic liquid processor (Model
VC505, Sonic & Materials, Newtown, CT, USA) for 60 s.
The solution was kept in an ice water bath during sonic-
ation to avoid DDFP evaporation. The sonication step pro-
duced perfluorocarbon droplets with a lipid shell which
were stable at physiological temperature. In the last step,
the emulsion was forced 16 times at 20°C through a poly-
carbonate membrane with 200-nm pores (Whatman,
Kent, ME, USA) using an extruder (10-ml LIPEX extruder,
Northern Lipids, BC, Canada), yielding a 10-ml narrowly
distributed suspension of DDFP nanodroplets. The
nanoemulsion was stored in a sealed vial and refrigerated
until further use. The size distribution of the nanoemulsion
was determined at 37°C with a particle size analyzer
(Model 90 Plus, Brookhaven Instruments, Holtsville,
NY, USA).
Fabrication of tissue-mimicking phantom
All the tests of bubble-enhanced lesion formation were
conducted in vitro using the albumin-containing acryl-
amide gel phantom originally developed by Lafon et al.
[39]. Slight modifications were made in order to uni-
formly distribute PSNE into the phantom and get better
lesion visualization of lesion formation via video record-
ing. The volume of each phantom was 2.65 × 2.65 ×
1.71 cm3. This size was sufficient for this study since the
largest lesion that was produced was 1 cm in length.
The phantom was prepared by first mixing 2.1 ml of
acrylamide (A9926, 40% 19:1 acrylamide/bis-acrylamide
solution, Sigma-Aldrich Corporation, St. Louis, MO,
USA), 1.2 ml of 1 M Tris buffer pH 8 (trizma hydro-
chloride and trizma base, Sigma-Aldrich Corporation),
0.1 ml of 10% (w/v) ammonium persulfate solution (APS,
Sigma-Aldrich Corporation), and 1.08 g of bovine serum
albumin (BSA, A3059, Sigma-Aldrich Corporation) in
water. The entire solution was degassed for 1 h at 40°C,
and then, PSNE was added. The mixture was stirred gently
to get a uniform distribution of nanodroplets, and
TEMED (87689, Sigma-Aldrich Corporation) was added
last to initiate polymerization (1 μl TEMED/ml phantom
solution). The phantom was submerged in a 12°C water
bath during polymerization to remove the heat generated
by the exothermic reaction. The volume fraction of DDFP
in phantoms was used to describe the concentration of
PSNE added, assuming that no DDFP was lost during
emulsification and polymerization of the gels. Six different
PSNE volume fractions were used for these experiments:
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where 0.000% was used as the control case.
APS and TEMED in the recipe served as the cross linker
and free radical generator, respectively. BSA served as an
indicator of HIFU thermal ablation, as it denatures and
turns white with sufficient heating [23,39]. Since polyacryl-
amide gels are optically transparent, the denaturation of
BSA was recorded real time using a hard disk drive cam-
corder with a 30-Hz frame rate (Everio, JVC, Yokohama,
Japan). BSA also increases the attenuation coefficient of
the gel. The speed of sound, density and attenuation of
this type of phantom, as measured by Lafon et al. [39] at
room temperature (22°C), were 1,044 ± 15 kg/m3, 1,544 ±
11 m/s, and 0.068 Np/cm at 3.2 MHz, respectively. All
phantoms in this study were used on the same day of
polymerization.
Experimental setup
The experimental setup is presented in Figure 1. All the
tests were conducted in an optically transparent acrylic
water tank with a volume of 20 × 30 × 20 cm3 (width ×
length × height). The tank was filled with degassed water
(dissolved oxygen concentration of 30%) using a degassing
filter (MiniModule, Membrana, Wuppertal, Germany),
and the water temperature was maintained at 37°C using
a water heater (Model VPT-107, Omega Engineering,
Stamford, CT, USA). Due to the lack of water circulation
during the experiments, it is likely that there was a depth-
dependent temperature gradient in the water tank. Thus,Figure 1 Experimental setup. A schematic of the setup for the
polyacrylamide gel phantom experiments, indicating the relative
positions of the HIFU transducer, the passive cavitation detector
(PCD), the thermocouple, and the video camera. The electrical
connections between equipment used in the experiments are also
indicated in the figure.the phantoms were placed at the same depth for each ex-
periment in order to obtain consistent results. Two ultra-
sound transducers were used: one serving as the power
transducer, and the other serving as the passive cavitation
detector (PCD). These two transducers were positioned
perpendicular so as to be confocal to each other to in-
crease the signal-to-noise ratio of the PCD. The transduc-
ers were aligned by performing pulse-echo measurements
with a 4-mm aluminum bead that was suspended in the
water tank. The volume of the overlapping foci was very
small (<0.1 mm3); thus, the PCD may not have been able
to detect cavitation activity beyond the focal region.
Nevertheless, it is expected that the majority of PSNE
vaporization occurred within the focal volume; thus, the
cavitation measurements were informative. The phantom
was positioned at the focus of the power transducer in a
custom-built acrylic holder, which had Tegaderm-covered
windows on all sides to allow ultrasound transmission. A
hard disk drive camcorder (Everio, JVC) with a 30-Hz
frame rate was used to record the lesion formation from
the outside of the water tank. All videos were recorded
and processed after tests with an image processing code
written in Matlab (Mathworks, Natick, MA, USA).
Power transducer calibration
The power transducer was a single-element spherically fo-
cused transducer with a 64-mm aperture and a 63-mm ra-
dius of curvature (Model H-102, Sonic Concepts,
Woodinville, WA, USA). The power transducer was driven
at its third harmonic (3.2 MHz), and the focal width and
depth (pressure full width at half maximum (FWHM))
were 0.42 and 4.5 mm, respectively, at a temperature of
37°C. The excitation signal was provided by two function
generators (33250A, Agilent, Santa Clara, CA, USA) in
series with a 150-W RF amplifier (ENI A150, Rochester,
NY, USA). As the desired waveforms in the tests were a
short, high-amplitude pulse followed by CW exposure, two
function generators were used. The first function generator
delivered the ADV pulse and was triggered with the com-
puter, while the second function generator was triggered
by the first after the high-amplitude pulse was sent. A TTL
delay circuit was used between the function generators to
avoid overlap between the ADV pulse and CW exposure.
The amplifier output impendence was matched to the
transducer impedance via a matching network provided by
the manufacturer. The acoustic power output of the trans-
ducer was calibrated with radiation force balance method as
a function of the electrical input power [40], and the elec-
trical power was measured with a power meter (E4419B,
Agilent). The uncertainty of the measurements was 7%.
Passive cavitation detection
A 2-MHz single-element spherically focused transducer
with a 64-mm aperture and a 63-mm radius of curvature
Table 1 Ultrasound parameters: free-field acoustic powers
and intensities to explore effect of PSNE vaporization on
lesion formation
Parameter name Acoustic power (corresponding intensity)
Initial pulse (30 cycle) Continuous signal (15 s)
Vaporization pulse 6.4 W (I = 4586 W/cm2) 0.8 W (I = 550 W/cm2)
Heating (NVP1) 0.8 W (I = 550 W/cm2) 0.8 W (I = 550 W/cm2)
Heating (NVP2) 2.7 W (I = 1957 W/cm2) 2.7 W (I = 1957 W/cm2)
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ord cavitation emissions. The PCD had a focal width and
depth (pressure FWHM) of 0.73 and 7 mm, respectively,
at a frequency of 2 MHz. The signal from the passive
transducer was filtered with a 1.6–2.2 MHz band-pass fil-
ter (Allen Avionics, Mineola, NY, USA) to suppress the
fundamental frequency of the HIFU source. A low-noise
preamplifier (Model DHPVA-100, Femto, Berlin, Germany)
was used to amplify the filtered signal by 20 dB, and the
amplified signal was digitized (14-bit dual-channel digitizer,
Gage, Lockport, IL, USA) and stored on the computer.
The sampling rate of the digitizer was set at 10 MS/s and
recorded 2,024 data points every 5 ms. Figure 2 shows an
example of the power spectrum of two segments, recorded
with and without cavitating bubbles, respectively. The
power density was integrated between 1.7 and 2.1 MHz
and used as the IC dose of that segment. This frequency
range was chosen due to the bandwidth of the 2-MHz
PCD and to minimize the contribution from energy at
the 1.6-MHz subharmonic peak. The noise floor was ap-
proximately four orders of magnitude below the cavita-
tion signal.
Experimental methods
Exposure conditions
The exposure conditions used in this study to evaluate
bubble-enhanced heating and lesion formation are listed
in Table 1. The transmitted acoustic power was mea-
sured using a radiation force balance, and the spatial
average-temporal average acoustic intensity was approxi-
mated by dividing the measured acoustic power by theFigure 2 A typical example of normalized PSD in gel phantom
with vaporized and unvaporized PSNE. The solid line represents
the signal with vaporized PSNE, and the dashed line indicates the
signal with unvaporized PSNE. The increase in broadband emissions
around 2 MHz indicates the presence of inertial cavitation activity.
Power density was integrated between 1.7 and 2.1 MHz and used as
the IC dose of that segment. This frequency range was chosen due
to the bandwidth of the 2-MHz PCD and to minimize the
contribution from energy at the 1.6-MHz subharmonic peak.calculated FWHM cross-sectional area. All gels were
sonicated with a 30-cycle tone burst followed by CW ex-
posure for 15 s. PSNE-loaded gels were subjected to a
tone burst with the acoustic power that was above
(vaporization pulse (VP)) or below (non-vaporizing con-
trol pulse (NVP1)) the threshold for PSNE vaporization.
Before commencing studies, we determined the pressure
threshold for PSNE vaporization, which is dependent on
the temperature, acoustic frequency, and pulse duration
[41]. Using an acoustic method described previously to
detect and quantify broadband emissions radiated by
PSNE during vaporization [29], the free-field vapori-
zation threshold for 3.3-MHz exposures at 37°C was de-
termined to be 3.80 ± 0.27 W (I = 2,714 W/cm2) for a
30-cycle pulse. The vaporization threshold was identified
by a nonlinear increase in the detected broadband emis-
sions, as previously described [29].
Temperature measurement with thermocouple
A needle thermocouple (0.2 mm, Model HYP-0, Omega
Engineering, Stamford, CT, USA) was used in some exper-
iments to measure temperature elevations during ultra-
sound exposures with and without PSNE vaporization.
The thermocouple was inserted into the phantom at the
HIFU focal plane, parallel to the HIFU axis and 0.63 mm
off axis laterally, where the acoustic pressure was reduced
by 67% compared to the pressure at the focus. The
thermocouple was placed out of the axis plane of the two
transducers to avoid interference with PCD measure-
ments. The thermocouple signal was amplified (Model
SCXI-1112, National Instrument, Austin, TX, USA), digi-
tized (Model PCI-6035E, National Instrument), and stored
in the computer. The system was calibrated as described
previously [29], and the accuracy was determined to be
±0.3°C. The alignment of the thermocouple to the HIFU
beam was conducted in two steps. First, the needle
thermocouple was inserted into the polyacrylamide gel
under the guidance of a B-mode ultrasound (Terason
2000, Terason Ultrasound, Burlington, MA, USA). Sec-
ond, the power transducer provided a pulsed sinusoid sig-
nal with 50% duty cycle and 1 Hz pulse repetition
frequency. The phantom was moved until a maximum
rate in the temperature rise during the HIFU on time was
measured (dT < 5°C) [16,42]. In the experiments,
Figure 3 An example of the image processing procedure
(A, B, C). 1 represents the lesion length and 2 represents the shift of
lesion center with respect to focal plane (solid gray line). The lesion
was divided into two parts by its middle point, and the volume of
each part was calculated (VPre and VPost). The ultrasound source was
located to the right of the image. The scale bar represents 5 mm.
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rameters NVP1 and VP with a thermocouple inside a
phantom mixed with 0.012% PSNE, and the correspond-
ing PCD data were also recorded for comparison.
Monitoring lesion formation
All the tests were conducted with polyacrylamide gels
separated into two groups. The first group was designed
to test the feasibility of using vaporized PSNE to reduce
the time or acoustic intensity required for lesion forma-
tion. The PSNE volume fraction was either 0.000%
(sham), 0.008%, or 0.020%, and five tests were made for
each volume fraction. In addition, four different acoustic
intensities between 156 and 2,397 W/cm2 (with 7% un-
certainty) were tested, with five tests at each intensity.
All gel phantoms were sonicated with parameter VP
(acoustic power of the tone burst exceeded vaporization
threshold), NVP1 (acoustic power of the tone burst was
below vaporization threshold), or NVP2 (acoustic power
that is sufficient to cause lesion formation in the phan-
toms that did not contain PSNE). The second group was
designed to investigate the effects of PSNE concentra-
tion in the lesion formation. Six different PSNE volume
fractions were chosen (0.000%, 0.004%, 0.008%, 0.012%,
0.016%, 0.020%), and for each volume fraction, four or
five sonications were made with parameters VP and
NVP1. For all tests, the PCD and video data were
recorded, stored, and processed later.
Image processing and statistics of lesion geometry
All videos were analyzed using an image processing code
written in Matlab. Using the code, the HIFU on/off time,
location of the focal plane and lesion, and the geomet-
rical lesion dimensions were obtained. The focal plane
was determined each day by identifying the center of a
symmetric lesion in a phantom without PSNE, and this
location was used as the focal plane for all other experi-
ments conducted that day. The key algorithm in this
code was lesion detection, which was designed based on
background subtraction with suitable noise filtration
methods. Figure 3 shows an example of how the code
worked for each frame. First, the location of lesion in
the video was detected and cropped (Figure 3A), and
then the background was removed by subtracting a
frame which was acquired before the sonication began.
Next, the image was smoothed with a Gaussian filter
and rescaled linearly for better image quality (Figure 3B).
In addition, the position of the focal plane was calcu-
lated. The background noise threshold was determined
by measuring the peak gray-scale pixel intensity in a
video of a phantom without ultrasound exposure. All
other acquired videos were thresholded using this value
in order to identify the lesion boundary. Because only
2D information about lesions was available from theimages, lesions obtained in this study were assumed to
be axially symmetrical. This approximation was verified
during the experiments by visually examining the lesions
after sonication. Finally, the lesion dimensions, including
length and center location relative to the focal plane,
and the distortion (i.e., degree of prefocal lesion forma-
tion) in lesion shape along the HIFU axis were deter-
mined from the processed images (Figure 3C).
The lesion volume was estimated using a method pre-
viously described [23,43]. Assuming that the lesions were
symmetrical around the long axis, the volume (V) could
be approximated according to the following equation:
V ¼
XN
i¼1π  rið Þ
2  Cp; ð1Þ
where N is the total number of pixels along the axis, r is
the distance in pixels from the lesion border of that slice
to its central axis, and Cp is the length of each pixel in mil-
limeters. It has been reported that the presence of cavita-
tion or boiling will cause lesion distortion along the HIFU
axis [21,22]. By assuming that the lesion was divided into
two parts with its middle point along the axis, the volumes
of the proximal and distal parts of the lesion relative to
the transducer were calculated as Vpre and Vpost, respect-
ively. A distortion coefficient was then defined as Vpre/
Vpost to represent the degree of distortion. If no distortion
occurred, the lesion had a cigar shape and the coefficient
was approximately equal to one. If distortion did occur,
Figure 5 A typical example of temperature in PSNE-containing
gel phantom with and without a vaporization pulse. A
polyacrylamide gel phantom containing PSNE (volume fraction of
0.012%) was sonicated with VP (solid line) or NVP1 (dashed line)
exposure conditions (see Table 1). The thermocouple was located
0.63 mm off axis laterally, where the acoustic pressure was 67% of
the pressure at the focus. Ultrasound was transmitted continuously
at an intensity of 550 W/cm2 between t = 0 s and t = 15 s.
Vaporization of PSNE significantly accelerated heating in the gel
phantom as compared to phantoms with unvaporized PSNE.
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Results
Size distribution of nanoemulsions
An example of the size distribution measured for the
nanoemulsion is shown in Figure 4 (16 passes, solid line).
The size distribution of the nanoemulsion before the extru-
sion is also shown in Figure 4 (0 passes, dashed line). Com-
paring the results before and after extrusion, we find that
forcing the nanoemulsion 16 times through a membrane
with a 200-nm pore size helped to reduce the polydisper-
sity in the size distribution. Furthermore, the results sug-
gest that the mean size of the nanoemulsion post-extrusion
depends upon the membrane pore size. Therefore, the ex-
trusion technique is extremely useful in the preparation of
nanoemulsions where a predetermined particle size is de-
sired. The mean diameter for all nanoemulsions extruded
through the 200-nm membranes in this study was 173 nm
with a standard deviation of 5 nm. A previous study found
that microbubbles formed from vaporized droplets ex-
panded in size six to ten times the original droplet diameter
[44]. Thus, it is anticipated that the droplets used in this
study would form micron-sized bubbles after vaporization.
Temperature and passive cavitation detection
Figure 5 shows the temperature elevation with and without
PSNE vaporization in a phantom loaded with PSNE at a
volume fraction of 0.012%. For these tests, gel phantoms
were subjected to a CW exposure at an acoustic intensity
of 550 W/cm2 for 15 s. In all tests, CW exposures wereFigure 4 The size distribution of nanoemulsion particles before
and after extrusion. The dashed line represents the distribution
before extrusion, and the solid line indicates the distributions after
extruding 16 times through polycarbonate membrane filters with a
200-nm pore size. Extrusion produced PSNE with a smaller mean
diameter and a narrower size distribution. The measurement
uncertainty was 1.1% (calculated from the variation in mean size
after repeating the measurement five times with the same sample).preceded by a 30-cycle tone burst at an acoustic power
above (VP) or below (NVP1) the PSNE vaporization thresh-
old. For gels in which PSNE was vaporized, the temperature
rose significantly in the first 2 s. The temperature then
dropped a few degrees and remained level through the
remaining sonication time. An example of the inertial cavi-
tation dose (normalized by the initial cavitation dose mea-
sured at the onset of sonication with PSNE) is plotted as a
function of the sonication time in Figure 6. No evidence of
inertial cavitation was detected for gels sonicated without
PSNE vaporization (NVP1), while strong IC emission was
detected immediately after PSNE vaporization (VP). How-
ever, the magnitude of broadband emissions dropped sig-
nificantly in the first 2 s and was negligible for t > 3 s. This
trend was observed in all tests where PSNE were vaporized.
By comparing Figures 5 and 6, we can see a relationship be-
tween the temperature elevation and the IC dose. The ob-
served acceleration in heating coincided in time with the
presence of broadband emissions from inertial cavitation.
Once the IC dose reached zero, the temperature measured
with the needle thermocouple during HIFU exposure in-
creased by only a few degrees. This suggests that inertial
cavitation contributed significantly to the accelerated
heating measured after vaporized PNSE, which is consist-
ent with findings from previous studies [10,11,45].
Effect of vaporized PSNE on HIFU-mediated lesion
formation
Images of lesion formation are shown over a 15-s expos-
ure at PSNE volume fractions of 0.000% (control) and
Figure 6 Inertial cavitation dose as a function of time with and
without a vaporization pulse. The inertial cavitation dose,
averaged between 1.7 and 2.1 MHz and normalized by the initial
cavitation dose measured at the onset of sonication with PSNE, is
plotted for the tests shown in Figure 5. Note that the time is plotted
on a logarithmic scale. The peak temperature rise in Figure 5
corresponded to the time when the inertial cavitation dose was at
its peak (within 1 s of vaporization).
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2.5 s with PSNE compared to 7.5 s without PSNE. Also,
a plot of the change in lesion volume over time for dif-
ferent combinations of exposure conditions (see Table 1)
is shown in Figure 8. It is shown that the onset of lesion
formation started earlier (i.e., 1.5 s) in a gel at a lower in-
tensity (i.e., 550 W/cm2) when PSNE were vaporized be-
fore CW exposure. In comparison, evidence of the onset
of lesion formation in gels without PSNE and subjected
to more intense ultrasound (i.e., 1,957 W/cm2) was not
seen until 7.5 s after the start of sonication. Another
noteworthy result from this part of the study was the
fact that lesions formed at an acoustic intensity of 550
W/cm2 after vaporization of PSNE at a volume fraction
of 0.008% still had a symmetric shape (Figure 7).
Effect of PSNE concentration on lesion formation
The effect of PSNE concentration (i.e., DDFP volume
fraction) on lesion volume, distortion, and center shift is
plotted in Figure 9 (N = 5). All the results shown in this
section were from tests performed with VP exposure
conditions. Although tests with NVP1 exposure condi-
tions were also conducted, no lesions were formed, and
thus, no measurements could be made. The results show
that either no lesion or small lesions (volume < 4 mm3)
were formed with 0.004% PSNE. This suggests that a
minimum density of cavitation nuclei or a longer CW
exposure time is needed to take advantage of bubble-
enhanced heating at this PSNE concentration and acous-
tic intensity. At an applied acoustic intensity of 550 W/
cm2, there was no significant difference in the size,shape, and variance of lesions formed in gels containing
0.008% to 0.020% PSNE.
Effect of acoustic intensity on lesion formation with
vaporized PSNE
The lesion volume, distortion, and center shift are plot-
ted as a function of continuous wave acoustic intensity
at PSNE concentrations of 0.000% (control), 0.008%, and
0.020% in Figure 10. The lesion volume increased with
acoustic intensity and was significantly enhanced by
PSNE. We determined that the minimum acoustic inten-
sity required to denature albumin in 15 s without vapor-
ized PSNE was 1,479 W/cm2 (the volume of denatured
albumin in this case was not measurable) compared to a
minimum acoustic intensity of 157 W/cm2 with PSNE
(uncertainties of 7%). Thus, it was possible to denature
albumin in 15 s using 89% less acoustic power by first
vaporizing PSNE. In general, the distortion and center
shift were larger at higher intensities, although no differ-
ence was observed at acoustic intensities between 1,844
and 2,396 W/cm2. In addition, no statistically significant
differences in the lesion sizes and shapes were observed
for PSNE concentrations of 0.008% and 0.020%. Represen-
tative images of lesions formed at different continuous
wave acoustic intensities are shown in Figure 11 for a
PSNE concentration of 0.020%. The lesion geometry was
very symmetric at an acoustic intensity of 157 W/cm2, but
the lesions become asymmetric at acoustic intensities of
830 W/cm2 and greater. The inertial cavitation dose is
plotted in Figure 12 as a function of continuous wave
acoustic intensity for the conditions tested in Figure 10.
The detected inertial cavitation dose increased with acous-
tic intensity and was greater for phantoms containing va-
porized PSNE.
Discussion
While this study is a continuation of our research on nu-
cleating bubbles with PSNE for the enhancement of
ultrasound-mediated thermal ablation, we have made
significant modifications to the protocol for making the
nanoemulsions in order to produce them at a more opti-
mal size for future in vivo applications. The addition of
extrusion to the protocol narrowed the size distribution
and reduced the mean diameter of the nanoemulsions
(Figure 4). For this study, nanoemulsions were produced
with a mean diameter below 200 nm. This is advantageous
for in vivo applications since sizes below 200 nm are opti-
mal for passive accumulation in tumors through the en-
hanced permeability and retention effect [37]. Additionally,
we coated the nanoemulsions with a mixture of phospho-
lipids instead of albumin, which was used as the emulsifier
in our previous study. Phospholipids can be conjugated
with poly(ethylene glycol) (PEG), a polymer which has
been shown to limit liposome aggregation and maintain a
Figure 7 Image sequences of lesion formation in phantoms with PSNE concentrations of 0.000% and 0.008%. The control phantom
(PSNE concentration of 0.000%) was sonicated with a 30-cycle tone burst followed by CW for 15 s, and the acoustic intensity was constant at
1,957 W/cm2. The phantom with 0.008% PSNE was sonicated with VP exposure condition (see Table 1). Lesions formed more rapidly in gel
phantoms containing PSNE. The white vertical line on each image represents the focal center.
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it has been shown that PEG increases the circulation
time of systemically administered liposomes in vivo
[48-50]. Thus, we speculate that coating our nano-
emulsions with PEGylated lipids will increase the circula-
tion time in vivo, and this is the subject of an ongoing
study. PSNE have no known toxicity, and the compo-
nents of PSNE (DDFP and PEGylated lipids) have previ-
ously been tested clinically [36,51].
The primary objective of this study was to investigate
the effect of vaporized PSNE on the time or acoustic
power required for lesion formation. Studies were con-
ducted with albumin-containing polyacrylamide gel phan-
toms because it allowed for control of the concentration of
PSNE added as well as real-time visual observation of lesion
formation. Variations in the lesion dimensions between ex-
periments were observed with phantoms containing PSNE.Although care was taken during phantom preparation to
ensure that the PSNE were well mixed within the acryl-
amide solutions, it was challenging to produce a perfectly
uniform distribution of PSNE within the gel phantoms.
Even tiny differences in the PSNE distribution within the
phantoms can have a significant effect on the cavitation ac-
tivity and thus heating rates, which can cause variation in
lesion formation. For this reason, five experiments were
performed for each condition tested. First, we confirmed
that vaporized PSNE could nucleate inertial cavitation and
accelerate HIFU-mediated heating within the phantom
above the albumin denaturation temperature threshold.
When PSNE were vaporized before CW exposure, the peak
temperature measured outside the focal volume exceeded
70°C within 5 s (Figure 5). Provided the PSNE volume
fraction was at least 0.008%, albumin denaturation was
observed within 5 s in hydrogels treated after PSNE
Figure 9 Effect of PSNE volume fraction on lesion formation.
(A) Volume, (B) distortion, and (C) center shift of lesions as a
function of PSNE volume fraction at an acoustic intensity of 550 W/
cm2 with VP exposure condition (see Table 1). No statistically
significant differences were observed between lesions formed with
PSNE volume fractions above 0.004%. Error bars represent the
standard deviation from five measurements.
Figure 8 Rate of growth in lesion volume as a function of PSNE
volume fraction and ultrasound exposure conditions. The
ultrasound exposure conditions are listed in Table 1. Lesion
formation in gel phantoms containing vaporized PSNE was
enhanced compared to that in controls.
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form a lesion of measurable volume (9 mm3) after PSNE
vaporization (0.008% volume fraction) using 72% less
power than the minimum required to denature albumin
without vaporized PSNE (550 vs. 1,957 W/cm2, respect-
ively). Furthermore, we found that the minimum acoustic
intensity to denature albumin within 15 s is 89% less after
PSNE vaporization (157 vs. 1,479 W/cm2). The reduction
in acoustic power for lesion formation may have a signifi-
cant impact on clinical applications of bubble-enhanced
HIFU for cancer therapy, in particular for the treatment of
brain and liver tumors. This reduction in power percent-
age (72%) to form measurable lesions exceeds the reduc-
tion in power percentage (30%) reported from a study of
the effect of UCA on ultrasound-mediated thermal abla-
tion in polyacrylamide gels [23]. The difference in the re-
duction in power percentage is most likely due to
attenuation of the transmitted acoustic waves in the gel by
UCA prefocally. In our study, bubbles are not present
along the beam path and the attenuation of PSNE is negli-
gible compared to the polyacrylamide gel. Therefore, it is
possible to localize the effect of bubbles on ultrasound-
mediated heating and thermal ablation by vaporizing
PSNE only at the transducer focus.
Lesions formed after PSNE vaporization had a predict-
able symmetric cigar shape at acoustic intensities between
157 and 550 W/cm2. However, at intensities greater than
830 W/cm2, the lesions formed a teardrop shape similar to
other studies of lesions formed in gels and tissue in the
presence of bubbles [12,21,52]. Based upon these observa-
tions, there may potentially be an optimal range of acoustic
intensities that allow for taking advantage of bubble-
enhanced heating while avoiding distortion in lesion shape.
The symmetry and geometry of lesions formed at acousticintensities of 157 W/cm2 (Figure 11) and 550 W/cm2
(Figure 7) were comparable to the lesions formed without
PSNE vaporization. The symmetric cigar shape is advanta-
geous for planning bubble-enhanced HIFU tumor ablation
Figure 10 Effect of acoustic intensity on lesion formation.
(A) Volume, (B) distortion, and (C) center shift of lesions as a
function of continuous wave acoustic intensity. All samples were
initially insonified with a 30-cycle, 6.4 W vaporization pulse. The
acoustic intensity had a significant effect on the lesion volume,
distortion, and center shift in gel phantoms containing PSNE. Error
bars represent the standard deviation from five measurements.
Figure 11 Comparison of lesion geometries at different
acoustic intensities. It can be seen that the lesion becomes
asymmetric at higher intensities. The PSNE volume fraction was
0.020% for all lesions.
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ever, it is important to note that lesions formed in the
presence of vaporized PSNE still migrated towards the
transducer, which must be accounted for in treatment
planning. In addition to maintaining symmetry in lesion
shape at low acoustic intensities (<550 W/cm2), the lesion
volume was comparable in gels containing 0.008% and
0.020% PSNE. This was unexpected as several studies have
reported an increase in the volume ablated by ultrasound
in the presence of bubbles [24,25,53]. For example,
Kaneko et al. reported that the volume of lesions formed
in tumors after systemic administration of Levovist wasFigure 12 Inertial cavitation dose at different acoustic
intensities and PSNE concentrations. The inertial cavitation dose
corresponds to the tests in Figure 10. The inertial cavitation dose
increased with acoustic intensity and was greater in gel phantoms
that contained vaporized PSNE. Error bars represent the standard
deviation from five measurements.
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[54]. As an alternative to ultrasound contrast agents, Sokka
et al. used a 0.5-s, 300-W tone burst to nucleate bubbles at
the focus in a rabbit thigh [12]. In our study, the lesion vol-
ume was primarily determined by the volume in which
PSNE were vaporized. Thus, increasing the PSNE concen-
tration above 0.008% had no detectable effect on lesion
volume created at the aforementioned acoustic intensities.
Although the vaporized PSNE were localized to the
HIFU focal plane, the lesions formed due to bubble-
enhanced heating did tend to grow towards the trans-
ducer. Documented studies show that boiling may alter
the lesion location due to the backscatter of incident
waves by millimeter-sized bubbles [22,55,56]. Nonlinear
wave propagation may also move the peak HIFU intensity
towards the transducer, resulting in growth of the lesion
towards the transducer [57]. However, we did not observe
any center shift for lesions generated without PSNE
(Figure 7), which suggests that a shift in the lesion center
most likely was not due solely to nonlinear wave propaga-
tion. While a prefocal shift in the location of maximum
acoustic intensity due to nonlinear wave propagation may
not be responsible for the migration of the lesion; it may
shift the location of PSNE vaporization. Consequently, the
impact of microbubbles on HIFU-mediated heating will
be shifted towards the transducer, leading to the formation
of lesions in the prefocal region. Another factor is that
heating can induce changes in the acoustic attenuation of
the gel phantom which could shift the focal region. Fur-
ther studies on this topic are warranted as a sound funda-
mental understanding of the impact of cavitating bubbles
on lesion location, size, and shape which is essential to the
clinical translation of the technique for cancer therapy.Conclusions
In conclusion, the feasibility of using PSNE to accelerate
HIFU thermal lesion formation in albumin-containing gel
phantoms was demonstrated. Lipid-coated phase-shift
nanoemulsions were produced with a narrow size distribu-
tion (between 100 and 300 nm), which is important as the
pressure threshold for vaporizing PSNE depends upon the
droplet size. When driven to cavitate inertially, the bubbles
formed by vaporizing PSNE reduced the acoustic intensity
required for lesion formation in gel phantoms by as much
as 89%. In addition, at an acoustic intensity of 550 W/cm2,
the onset of lesion formation was reduced from 5 to 1 s
of insonation. Furthermore, symmetrical lesions can be
formed in the presence of bubbles provided that the
acoustic intensity is kept low (<550 W/cm2). These re-
sults suggest that PSNE could eventually improve the ef-
ficiency of HIFU-mediated thermal ablation of solid
tumors, thus potentially making bubble-enhanced HIFU
a viable option for cancer therapy.Competing interests
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